NovaBay Pharmaceuticals, Inc. Common Stock (NBY)

Stay up-to-date with the latest market trends one hour before the close of the markets on Wednesday. Explore the top gainers and losers during today's session in our detailed report.

Wednesday's session is buzzing with activity. Check out the stocks that are attracting the most attention and driving market activity!

On Wednesday, there are stocks with unusual volume. Let's take a look.

Let's have a look at what is happening on the US markets in the middle of the day on Wednesday. Below you can find the top gainers and losers in today's session.

There are notable gap-ups and gap-downs in today's session. Let's take a look at which stocks are gapping on Wednesday.

As we await the opening of the US market on Wednesday, let's delve into the pre-market session and discover the top gainers and losers shaping the early market sentiment.

NovaBay Pharmaceuticals Inc. jumps 66.57% to $1 in pre-market trading after major investment and leadership changes prevent liquidation.

Discover the top movers in Friday's pre-market session and stay informed about market dynamics.

NovaBay shares are trading higher after the company announced it reached a definitive agreement to sell its Avenova assets for $9.5 million to Physician Recommended Nutraceuticals.

NBY stock results show that NovaBay Pharmaceuticals missed analyst estimates for earnings per share and missed on revenue for the second quarter of 2024.

NovaBay Pharmaceuticals shares are lower by 66% over the trailing five sessions. The company last week announced the pricing of its public offering.

NovaBay Pharmaceuticals shares are trading lower by 61% during Friday's session. The company announced the pricing of its public offering.